- Home
- CTSH vs ALC Comparison
CTSH vs ALC Comparison
Compare CTSH & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSH
- ALC
- Stock Information
- Founded
- CTSH 1994
- ALC 1945
- Country
- CTSH United States
- ALC Switzerland
- Employees
- CTSH N/A
- ALC N/A
- Industry
- CTSH EDP Services
- ALC Ophthalmic Goods
- Sector
- CTSH Technology
- ALC Health Care
- Exchange
- CTSH Nasdaq
- ALC Nasdaq
- Market Cap
- CTSH 40.0B
- ALC 41.0B
- IPO Year
- CTSH 1998
- ALC N/A
- Fundamental
- Price
- CTSH $77.81
- ALC $84.37
- Analyst Decision
- CTSH Hold
- ALC Strong Buy
- Analyst Count
- CTSH 17
- ALC 14
- Target Price
- CTSH $81.69
- ALC $102.53
- AVG Volume (30 Days)
- CTSH 2.7M
- ALC 801.5K
- Earning Date
- CTSH 02-05-2025
- ALC 02-25-2025
- Dividend Yield
- CTSH 1.54%
- ALC 0.31%
- EPS Growth
- CTSH 10.28
- ALC 156.61
- EPS
- CTSH 4.52
- ALC 2.34
- Revenue
- CTSH $19,412,000,000.00
- ALC $9,761,000,000.00
- Revenue This Year
- CTSH $4.03
- ALC $5.43
- Revenue Next Year
- CTSH $6.15
- ALC $6.42
- P/E Ratio
- CTSH $17.22
- ALC $35.98
- Revenue Growth
- CTSH N/A
- ALC 5.25
- 52 Week Low
- CTSH $63.79
- ALC $74.30
- 52 Week High
- CTSH $82.46
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- CTSH 49.88
- ALC 46.68
- Support Level
- CTSH $76.26
- ALC $82.31
- Resistance Level
- CTSH $78.14
- ALC $83.68
- Average True Range (ATR)
- CTSH 1.57
- ALC 1.04
- MACD
- CTSH 0.12
- ALC 0.14
- Stochastic Oscillator
- CTSH 58.30
- ALC 59.71
About CTSH Cognizant Technology Solutions Corporation
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.